I can’t comprehend how you come up with the thought Le Maître could have bought out AHZ for $45 mill Lex . How did you come up with that assumption ? If the company was on the open market including Cardiocel / TAVR and the ADAPT IP I doubt Le Maître could even come up with the cash needed to outbid the bigger players . 45 mill is lunch money for Edwards and the likes
Ann: First in human trial commences, page-47
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.90 |
Change
1.050(9.68%) |
Mkt cap ! $251.5M | |||
| Open | High | Low | Value | Volume |
| $11.00 | $11.90 | $10.85 | $504.4K | 45.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $11.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.90 | 99 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |